评论：杰恩等人《新西兰低剂量计算机断层扫描肺癌筛查项目的成本效益》。《肺癌》2018年，第124卷，第233 - 240页。2018年10月1日。DOI: 10.1016/j.lungcan.2018.08.004 。 - Suppr | 超能文献

Comment on: Jaine et al Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand. Lung Cancer 2018, 124, 233-240. 2018/10/01. DOI: 10.1016/j.lungcan.2018.08.004.

作者信息

Crengle Sue

机构信息

Department of Preventive and Social Medicine Dunedin, School of Medicine University of Otago, Dunedin, New Zealand.

出版信息

Lung Cancer. 2020 Jul;145:219-220. doi: 10.1016/j.lungcan.2020.04.008. Epub 2020 May 16.

DOI:10.1016/j.lungcan.2020.04.008

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Comment on: Jaine et al Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand. Lung Cancer 2018, 124, 233-240. 2018/10/01. DOI: 10.1016/j.lungcan.2018.08.004.评论：杰恩等人《新西兰低剂量计算机断层扫描肺癌筛查项目的成本效益》。《肺癌》2018年，第124卷，第233 - 240页。2018年10月1日。DOI: 10.1016/j.lungcan.2018.08.004 。

Lung Cancer. 2020 Jul;145:219-220. doi: 10.1016/j.lungcan.2020.04.008. Epub 2020 May 16.

2

Cost-effectiveness of a low-dose computed tomography screening programme for lung cancer in New Zealand.新西兰低剂量计算机断层扫描肺癌筛查计划的成本效益分析。

Lung Cancer. 2018 Oct;124:233-240. doi: 10.1016/j.lungcan.2018.08.004. Epub 2018 Aug 6.

3

Lack of benefit from low dose computed tomography in screening for lung cancer - comment on paper by Huang K-L et al.低剂量计算机断层扫描筛查肺癌不获益 - 评论 Huang K-L 等人的论文

BMC Pulm Med. 2020 Aug 26;20(1):225. doi: 10.1186/s12890-020-01252-1.

4

Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.低剂量计算机断层扫描在高危人群中的肺癌筛查：系统评价和经济评估。

Health Technol Assess. 2018 Nov;22(69):1-276. doi: 10.3310/hta22690.

5

The rationale for, and design of, a lung cancer screening program.肺癌筛查计划的原理和设计。

Cleve Clin J Med. 2012 May;79(5):337-45. doi: 10.3949/ccjm.79a.12018.

6

The cost-effectiveness of the Manchester 'lung health checks', a community-based lung cancer low-dose CT screening pilot.曼彻斯特“肺部健康检查”的成本效益，一项基于社区的肺癌低剂量 CT 筛查试点。

Lung Cancer. 2018 Dec;126:119-124. doi: 10.1016/j.lungcan.2018.10.029. Epub 2018 Nov 2.

7

Current estimate of costs of lung cancer screening in the United States.美国肺癌筛查当前的成本估算。

Thorac Surg Clin. 2015 May;25(2):205-15. doi: 10.1016/j.thorsurg.2014.12.005. Epub 2015 Mar 7.

8

Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening.理解成本效益分析：使用三种不同的肺癌筛查分析进行解释。

AJR Am J Roentgenol. 2015 Aug;205(2):344-7. doi: 10.2214/AJR.14.14038.

9

Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.国家肺癌筛查试验中计算机断层扫描筛查肺癌的成本效益分析。

J Thorac Imaging. 2015 Mar;30(2):79-87. doi: 10.1097/RTI.0000000000000136.

10

Long-term Oncologic and financial implications of lung cancer screening.肺癌筛查的长期肿瘤学及经济影响

Thorac Surg Clin. 2015 May;25(2):223-9. doi: 10.1016/j.thorsurg.2014.11.006. Epub 2015 Mar 11.

引用本文的文献

1

Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development.非酒精性脂肪性肝病发生的实验模型及新型治疗靶点

Korean J Physiol Pharmacol. 2023 Jul 1;27(4):299-310. doi: 10.4196/kjpp.2023.27.4.299.